Vera Therapeutics(VERA) - 2024 Q3 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2024 Vera Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40407 81-2744449 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.) 8000 Marina Boulevard, Suite 120 Brisbane, California 94005 (A ...